Welcome to our dedicated page for Iron Horse Acquisition II SEC filings (Ticker: IRHO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Iron Horse Acquisition II's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Iron Horse Acquisition II's regulatory disclosures and financial reporting.
Iron Horse Acquisition II Corp. received an updated ownership report showing that MMCAP International Inc. SPC and Asset Management Inc. together beneficially own 1,500,000 ordinary shares. This represents 5.7% of the company’s ordinary shares, with shared power to vote and dispose of all these shares.
The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Iron Horse Acquisition II Corp., but instead are reported on a passive basis under Schedule 13G/A.
Iron Horse Acquisition II Corp. is a Cayman Islands-based special purpose acquisition company (SPAC) formed to merge with a business, primarily in media, entertainment and AI. It raised $230,000,000 in its IPO and deposited the funds in a U.S. trust account at $10.00 per unit.
The SPAC has up to 24 months from the IPO closing to complete an initial business combination, with potential extensions subject to shareholder approval. If no deal is completed, it will liquidate and redeem all public shares at roughly the cash held in trust per share, while rights would expire worthless.
As of February 12, 2026, there were 29,320,000 ordinary shares outstanding. The company highlights significant risks including difficulty finding a suitable target, conflicts of interest for sponsors and directors, possible heavy dilution from additional financing, and regulatory reviews such as CFIUS for U.S. targets.